Evolutionary Genomics

Evolutionary Genomics Stock-Based Compensation

The Stock-Based Compensation (SBC) of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is 193,208.00 USD. In the previous year, Stock-Based Compensation (SBC) was 219,718.00 USD — a change of -12.07% (lower).

Stock-Based Compensation

193,208.00USD

YoY

-12.07%

Last updated:

Stock-Based Compensation (SBC) of Evolutionary Genomics is 2022 193,208.00 USD. Stock-Based Compensation (SBC) of Evolutionary Genomics was 2021 219,718.00 USD. It decreases by -12.07% lower compared to the previous year.

The Evolutionary Genomics Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2015
8,929.00 USD
Jan 1, 2016
101,840.00 USD
Jan 1, 2017
101,896.00 USD
Jan 1, 2018
98,577.00 USD
Jan 1, 2019
55,828.00 USD
Jan 1, 2020
219,718.00 USD
Jan 1, 2021
219,718.00 USD
Jan 1, 2022
193,208.00 USD
The Evolutionary Genomics Stock-Based Compensation history
YEARStock-Based CompensationYoY
193,208.00USD-12.07%
219,718.00USD0.00%
219,718.00USD+293.56%
55,828.00USD-43.37%
98,577.00USD-3.26%
101,896.00USD+0.05%
101,840.00USD+1,040.55%
8,929.00USD+9,818.91%
90.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Stock-Based Compensation (SBC) of Evolutionary Genomics is 193,208.00 USD in 2022.

Stock-Based Compensation (SBC) of Evolutionary Genomics changed from 219,718.00 USD to 193,208.00 USD, representing a -12.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics